These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20839299)

  • 1. New parameterization approaches of the LIE method to improve free energy calculations of PlmII-Inhibitors complexes.
    Valiente PA; Gil A; Batista PR; Caffarena ER; Pons T; Pascutti PG
    J Comput Chem; 2010 Nov; 31(15):2723-34. PubMed ID: 20839299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What determines the van der Waals coefficient beta in the LIE (linear interaction energy) method to estimate binding free energies using molecular dynamics simulations?
    Wang W; Wang J; Kollman PA
    Proteins; 1999 Feb; 34(3):395-402. PubMed ID: 10024025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into selectivity of peptidomimetic inhibitors with modified statine core for plasmepsin II of Plasmodium falciparum over human cathepsin D.
    Dali B; Keita M; Megnassan E; Frecer V; Miertus S
    Chem Biol Drug Des; 2012 Apr; 79(4):411-30. PubMed ID: 22129033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteases.
    Orrling KM; Marzahn MR; Gutiérrez-de-Terán H; Aqvist J; Dunn BM; Larhed M
    Bioorg Med Chem; 2009 Aug; 17(16):5933-49. PubMed ID: 19635672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calculation of binding free energies of inhibitors to plasmepsin II.
    Steiner D; Oostenbrink C; Diederich F; Zürcher M; van Gunsteren WF
    J Comput Chem; 2011 Jul; 32(9):1801-12. PubMed ID: 21488062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuum solvation models in the linear interaction energy method.
    Carlsson J; Andér M; Nervall M; Aqvist J
    J Phys Chem B; 2006 Jun; 110(24):12034-41. PubMed ID: 16800513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute and relative binding free energy calculations of the interaction of biotin and its analogs with streptavidin using molecular dynamics/free energy perturbation approaches.
    Miyamoto S; Kollman PA
    Proteins; 1993 Jul; 16(3):226-45. PubMed ID: 8346190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining methods for calculations of binding free energies: LRA, LIE, PDLD-LRA, and PDLD/S-LRA calculations of ligands binding to an HIV protease.
    Sham YY; Chu ZT; Tao H; Warshel A
    Proteins; 2000 Jun; 39(4):393-407. PubMed ID: 10813821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational analysis of plasmepsin IV bound to an allophenylnorstatine inhibitor.
    Gutiérrez-de-Terán H; Nervall M; Dunn BM; Clemente JC; Aqvist J
    FEBS Lett; 2006 Oct; 580(25):5910-6. PubMed ID: 17045991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the LIE Method for Binding Free Energy Calculations of Protein-Ligand Complexes.
    Miranda WE; Noskov SY; Valiente PA
    J Chem Inf Model; 2015 Sep; 55(9):1867-77. PubMed ID: 26180998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding affinity prediction with different force fields: examination of the linear interaction energy method.
    Almlöf M; Brandsdal BO; Aqvist J
    J Comput Chem; 2004 Jul; 25(10):1242-54. PubMed ID: 15139037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein surface roughness accounts for binding free energy of Plasmepsin II-ligand complexes.
    Valdés-Tresanco ME; Valdés-Tresanco MS; Valiente PA; Cocho G; Mansilla R; Nieto-Villar JM
    J Mol Recognit; 2018 Jan; 31(1):. PubMed ID: 28895236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calculation of the binding affinity of beta-secretase inhibitors using the linear interaction energy method.
    Tounge BA; Reynolds CH
    J Med Chem; 2003 May; 46(11):2074-82. PubMed ID: 12747779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrrolidine derivatives as plasmepsin inhibitors: binding mode analysis assisted by molecular dynamics simulations of a highly flexible protein.
    Luksch T; Blum A; Klee N; Diederich WE; Sotriffer CA; Klebe G
    ChemMedChem; 2010 Mar; 5(3):443-54. PubMed ID: 20112327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics simulations of the three dimensional model of plasmepsin II-peptidic inhibitor complexes.
    Pranav Kumar SK; Kulkarni VM
    Drug Des Discov; 2001; 17(4):293-313. PubMed ID: 11765133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
    van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
    J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissection of the pH dependence of inhibitor binding energetics for an aspartic protease: direct measurement of the protonation states of the catalytic aspartic acid residues.
    Xie D; Gulnik S; Collins L; Gustchina E; Suvorov L; Erickson JW
    Biochemistry; 1997 Dec; 36(51):16166-72. PubMed ID: 9405050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculation of the standard binding free energy of sparsomycin to the ribosomal peptidyl-transferase P-site using molecular dynamics simulations with restraining potentials.
    Ge X; Roux B
    J Mol Recognit; 2010; 23(2):128-41. PubMed ID: 20151411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superimposing the 27 crystal protein/inhibitor complexes of β-secretase to calculate the binding affinities by the linear interaction energy method.
    Liu S; Zhou LH; Wang HQ; Yao ZB
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6533-7. PubMed ID: 20937559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An estimation method of binding free energy in terms of ABEEMσπ/MM and continuum electrostatics fused into LIE method.
    Chen SL; Zhao DX; Yang ZZ
    J Comput Chem; 2011 Jan; 32(2):338-48. PubMed ID: 20662079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.